What does Solanbridge Group, Inc. do?

Solanbridge Group, Inc. (SLNX) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is SLNX's market cap?

Solanbridge Group, Inc. (SLNX) has a market capitalization of approximately $476,000, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does SLNX pay a dividend?

No — Solanbridge Group, Inc. (SLNX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

SLNX

Solanbridge Group, Inc.

OTC·Drug Manufacturers, Specialty & Generic · Healthcare

$0.00$0.00+0.00%

Market cap$476.00K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

+0.00%CAGR +0.00%

Select date range

FromTo

Jun 29, 2007Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

SLNX does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue$0.00

Net Income−$6.58K

Net Margin—

Operating Cash Flow−$158.30K

Capital Expenditures$0.00

Free Cash Flow−$158.30K

Return on Equity—

Return on Invested Capital−7.3%

Net Debt$252.95K

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for SLNX and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how SLNX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for SLNX and 80,000+ other tickers.

About Solanbridge Group, Inc.

Solanbridge Group, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses or assets. The company was formerly known as Solanex Management, Inc. and changed its name to Solanbridge Group, Inc. in January 2011. Solanbridge Group, Inc. was incorporated in 2000 and is headquartered in Lakewood, Colorado.

CEO: David J. Cutler
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: OTC
Employees: 0
Website: www.solanbridgegroup.com

Peers

Peers Tab

FITX

Creative Edge Nutrition, Inc.

Dakshidin Corporation

Cap

$1.8M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About SLNX

What does Solanbridge Group, Inc. do?: Solanbridge Group, Inc. (SLNX) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is SLNX's market cap?: Solanbridge Group, Inc. (SLNX) has a market capitalization of approximately $476,000, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does SLNX pay a dividend?: No — Solanbridge Group, Inc. (SLNX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.